Read More Pharma Industry News What is HARLIKU and how will Cycle’s FDA-approved AKU drug help patients starting July 2025? Cycle Pharmaceuticals secures FDA approval for HARLIKU™, the first approved treatment for alkaptonuria (AKU); launch in the U.S. expected July 2025. byPallavi MadhirajuJune 23, 2025